Qube Research & Technologies (QRT)’s AstraZeneca AZN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.82M	Sell	9,250 -8,600	-48%	-$1.66M	﹤0.01%	2230
2025 Q4	$3.28M	Sell	17,850 -9,450	-35%	-$1.66M	﹤0.01%	2002
2025 Q3	$4.19M	Buy	27,300 +15,100	+124%	+$2.29M	﹤0.01%	1861
2025 Q2	$1.71M	Buy	12,200 +7,850	+180%	+$1.1M	﹤0.01%	2262
2025 Q1	$639K	Sell	4,350 -19,550	-82%	-$2.83M	﹤0.01%	2459
2024 Q4	$3.13M	Buy	23,900 +7,200	+43%	+$1.01M	﹤0.01%	1703
2024 Q3	$2.6M	Buy	+16,700	New	+$2.7M	﹤0.01%	1672

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Qube Research & Technologies (QRT)'s AZN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in AstraZeneca (AZN) in Q1 2026: 382,048 shares worth $75.3M. The stake represents 0.08% of the portfolio and ranks #293 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in AZN as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in AZN in Q1 2018 and has held it in 19 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Qube Research & Technologies (QRT) held 382,048 shares of AstraZeneca worth $75.3M as of Q1 2026.
AstraZeneca was a new Qube Research & Technologies (QRT) position in Q1 2026.
AstraZeneca made up 0.08% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #293 holding.
Qube Research & Technologies (QRT) first reported a position in AstraZeneca in Q1 2018 and has held it in 19 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.